60 stories tagged with #pharmaceutical, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Pharmaceutical"
Alnylam Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by Alnylam Pharmaceuticals, Inc.…
Indivior Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by Indivior Pharmaceuticals, Inc.…
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2026 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2026 Earnings Call April 30, 2026 4:30 PM EDTCompany ParticipantsSharon Klahre - Vice President of Investor Relations...…
Phathom Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by Phathom Pharmaceuticals, Inc.…
Bristol-Myers Squibb Company 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by Bristol-Myers Squibb Company in conjunction with their 2026 Q1 earnings call.…
Form DEF 14A Recursion Pharmaceuticals For: 30 April
Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript
Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call April 30, 2026 4:30 PM EDTCompany ParticipantsLisa CaperelliMichael Raab - President, CEO & DirectorEric...…
Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call Transcript
Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call April 30, 2026 8:00 AM EDTCompany ParticipantsJason Thompson - Vice President of Investor...…
West Pharmaceutical: Multiple Growth Drivers Are A Tailwind
Form DEF 14A Syndax Pharmaceuticals For: 30 April
Amgen Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by Amgen Inc.…
Merck & Co., Inc. (MRK) Q1 2026 Earnings Call Transcript
Merck & Co., Inc. (MRK) Q1 2026 Earnings Call April 30, 2026 9:00 AM EDTCompany ParticipantsPeter Dannenbaum - Vice President of Investor...…
AbbVie: Balancing Potential Acquisition Impact With Positive Q1 2026 Earnings
AbbVie Q1 2026 results show strong revenue/EPS growth, improved valuation, and dividend appeal, despite acquisition chatter. Click for this ABBV stock update.…
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call Transcript
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call April 30, 2026 8:00 AM EDTCompany ParticipantsCharles Triano - SVP & Head of Investor...…
Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
Baxter International Inc. (BAX) Q1 2026 Earnings Call April 30, 2026 8:30 AM EDTCompany ParticipantsKevin Moran - Vice President & Head of Investor...…
Summit Therapeutics: It Still Feels Like The Market Got Ahead Of Itself
Summit Therapeutics stock is rated a Sell due to an over $17bn valuation unsupported by current fundamentals and competitive risks. Read more about SMMT here.…
Phathom Pharmaceuticals, Inc. (PHAT) Q1 2026 Earnings Call Transcript
Phathom Pharmaceuticals, Inc. (PHAT) Q1 2026 Earnings Call April 30, 2026 8:00 AM EDTCompany ParticipantsEric Sciorilli - Director of Business Development...…
Eli Lilly and Company (LLY) Q1 2026 Earnings Call Transcript
Eli Lilly and Company (LLY) Q1 2026 Earnings Call April 30, 2026 10:00 AM EDTCompany ParticipantsMike Czapar - Director of Investor RelationsDavid Ricks -...…
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2026 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2026 Earnings Call April 30, 2026 8:30 AM EDTCompany ParticipantsChristine Lindenboom - Chief Corporate...…
Alnylam Pharmaceuticals Q1 Earnings Call Highlights
Logista Integral, S.A. (CDNIF) Q2 2026 Earnings Call Transcript
Logista Integral, S.A. (CDNIF) Q2 2026 Earnings Call April 30, 2026 4:00 AM EDTCompany ParticipantsIsabel TroyaPedro Agustín Losada Hernández - Chief...…
Merck & Co., Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by Merck & Co., Inc.…
How AstraZeneca’s 17,000 AI-certified employees are helping it reach a ‘stretch goal’ of $80 billion in revenue
CFO Aradhana Sarin breaks down the building blocks behind the revenue target and reflects on a strong Q1.…
More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says
Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill.…
Novo Nordisk: Pricing Pressure And Falling Margins Make This A Value Trap (Q1 Earnings Preview)
Novo Nordisk faces sustained margin compression due to intensifying price competition in the GLP-1 weight loss drug market. Learn more about NVO stock here.…
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating at buy
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.…
Thom Tillis: Free markets built American prosperity. Government intervention puts it at risk
Price controls, patent seizures, and institutional investment bans will undermine the very system that made America the world's most dynamic economy.…
Telix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX597 Transcript
Telix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX597 April 29, 2026 7:30 PM...…
Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call Transcript
Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call April 29, 2026 4:30 PM EDTCompany ParticipantsBrian Lian - President, CEO & DirectorGregory Zante...…
Ionis Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-29. The following slide deck was published by Ionis Pharmaceuticals, Inc.…
Bausch Health Companies Inc. (BHC) Q1 2026 Earnings Call Transcript
Bausch Health Companies Inc. (BHC) Q1 2026 Earnings Call April 29, 2026 5:00 PM EDTCompany ParticipantsGaren Sarafian - VP & Head of Investor...…
Agios Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-04-29. The following slide deck was published by Agios Pharmaceuticals, Inc.…
Form DEF 14A Crinetics Pharmaceuticals For: 29 April
Pharma Giant Purdue Sentenced To $5.5 Billion For ‘Fueling The Opioid Epidemic’
'Putting countless lives at risk'…
Dr. Reddy’s Laboratories gets Health Canada nod for generic Semaglutide injection
Dr. Reddy’s Laboratories gains Health Canada approval for generic Semaglutide, enhancing diabetes treatment access for Canadian patients.…
Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Sofdra Update Transcript
Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Sofdra Update April 28, 2026 8:30 PM EDTCompany ParticipantsVincent...…
Orexo AB (publ) 2026 Q1 - Results - Earnings Call Presentation
2026-04-28. The following slide deck was published by Orexo AB (publ) in conjunction with their 2026 Q1 earnings call.…
Earnings call transcript: Botanix Pharmaceuticals Q3 2026 sees revenue growth
Form DEF 14A FENNEC PHARMACEUTICALS INC. For: 28 April
Form DEF 14A Zentalis Pharmaceuticals Llc For: 28 April
Form DEF 14A TARSUS PHARMACEUTICALS For: 28 April
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call April 28, 2026 8:30 AM EDTCompany ParticipantsJonathan Kirshenbaum - Investor...…
Form 144 Kiniksa Pharmaceuticals International For: 28 April
Aktis Oncology: 'Buy' Based On Radiotherapeutic Isotope Design For Broad Targeting
Aktis Oncology (AKTS) stock is given a "Buy" rating, driven by its innovative miniprotein radioconjugates targeting Nectin-4 and B7-H3 solid tumors. Read the full analysis here.…
Form 13G FENNEC PHARMACEUTICALS INC. For: 28 April
Madrigal Pharmaceuticals: Boom Or Bust In MASH? Regretfully, I'm Bearish
Madrigal Pharmaceuticals may struggle to generate blockbuster revenue for its only commercial candidate, Rezdiffra. Click here to read why MDGL is a Sell.…
Incyte Corporation (INCY) Q1 2026 Earnings Call Transcript
Incyte Corporation (INCY) Q1 2026 Earnings Call April 28, 2026 8:00 AM EDTCompany ParticipantsAlexis Smith - Vice President & Head of Investor...…
Telix Pharmaceuticals (TLX): How Are Its Clinical Programs Doing?
BofA raises Amylyx Pharmaceuticals stock price target on model updates
Santhera Pharmaceuticals Holding AG 2025 Q4 - Results - Earnings Call Presentation
2026-04-28. The following slide deck was published by Santhera Pharmaceuticals Holding AG in conjunction with their 2025 Q4 earnings call.…
Kiniksa Pharmaceuticals International, plc 2026 Q1 - Results - Earnings Call Presentation
2026-04-28. The following slide deck was published by Kiniksa Pharmaceuticals International, plc in conjunction with their 2026 Q1 earnings call.…
Kiniksa Pharmaceuticals International Q1 Earnings Call Highlights
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnings Call Transcript
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnings Call April 28, 2026 6:30 AM EDTCompany ParticipantsGuido Oelkers - CEO & PresidentLydia...…
Recursion: No Longer An AI 'Pet Science Project,' But Still A 'Sell'
Recursion Pharmaceuticals (RXRX) remains a 'Sell' as its ~$1.8B valuation is unsupported by clinical or commercial progress.…
Leerink raises Rocket Pharmaceuticals stock price target on PRV sale
Roche: Policy Overhang Clears, Fundamentals Intact, Upside Remains Limited But Positive
Roche's outlook improves as US pricing risk fades; Q1 growth and 2026 guidance hold. Find out why RHHBF stock is a Buy.…
Earnings call transcript: Santhera Pharmaceuticals’ H2 2025 revenue doubles
STAT+: Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
The Novartis CEO warned that Trump's drug pricing policy poses a “very difficult situation” and the reality will soon catch up with drugmakers and patients…
Novartis AG 2026 Q1 - Results - Earnings Call Presentation
2026-04-28. The following slide deck was published by Novartis AG in conjunction with their 2026 Q1 earnings call.…